Vitamin and mineral use and risk of prostate cancer: the case–control surveillance study
- 169 Downloads
Many studies have evaluated the association between vitamin and mineral supplement use and the risk of prostate cancer, with inconclusive results.
The authors examined the relation of use of multivitamins as well as several single vitamin and mineral supplements to the risk of prostate cancer risk among 1,706 prostate cancer cases and 2,404 matched controls using data from the hospital-based case–control surveillance study conducted in the United States. Odds ratios (OR) and 95% confidence intervals (CI) for risk of prostate cancer were estimated using conditional logistic regression model.
For use of multivitamins that did not contain zinc, the multivariable odds ratios of prostate cancer were 0.6 for 1–4 years, 0.8 for 5–9 years, and 1.2 for 10 years or more, respectively (p for trend = 0.70). Men who used zinc for ten years or more, either in a multivitamin or as a supplement, had an approximately two-fold (OR = 1.9, 95% CI: 1.0, 3.6) increased risk of prostate cancer. Vitamin E, beta-carotene, folate, and selenium use were not significantly associated with increased risk of prostate cancer.
The finding that long-term zinc intake from multivitamins or single supplements was associated with a doubling in risk of prostate cancer adds to the growing evidence for an unfavorable effect of zinc on prostate cancer carcinogenesis.
KeywordsCase–control study multivitamin Prostate neoplasm
This work was supported by grant CA45762 from the National Cancer Institute. Additional support was provided by grant FD-U-00082 from the Food and Drug Administration.
- 2.Cancer Statistics (2007) American Cancer Society, Inc, 2007. Available at: http://www.cancer.org/docroot/PRO/content/PRO_1_1_Cancer_Statistics_2007_Presentation.asp. Accessed May 11, 2008
- 7.NIH State-of-the-Science Panel (2006) National Institutes of Health State-of-the-science conference statement: multivitamin/mineral supplements and chronic disease prevention. Ann Intern Med 145:364–371. doi: 10.1001/archinte.145.2.364
- 29.Rosenberg L, Coogan P, Palmer J (2005) Case–control surveillance. In: Strom BL (ed) Pharmacoepidemiology. Wiley, Chichester, pp 185–202Google Scholar
- 31.Selenium and Vitamin E Cancer Prevention Trial (SELECT) (2008) U.S. National Cancer Institute. Available at: http://www.cancer.gov/newscenter/pressrelease/SELECTQandA. Accessed November 22, 2008
- 32.Clark LC, Combs GF Jr, Turnbull BW et al (1996) Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional prevention of cancer study group. JAMA 276:1957–1963. doi: 10.1001/jama.276.24.1957 PubMedCrossRefGoogle Scholar
- 35.Johansson M, Appleby PN, Allen NE et al (2008) Circulating concentrations of folate and vitamin B12 in relation to prostate cancer risk: results from the European prospective investigation into cancer and nutrition study. Cancer Epidemiol Biomarkers Prev 17:279–285. doi: 10.1158/1055-9965.EPI-07-0657 PubMedCrossRefGoogle Scholar